alert-icon

To increase patient access to care, on August 21, 2017, Whitman-Walker Health will change its appointment scheduling system. When you contact Whitman-Walker, you will now be able to schedule your visit within the next 10 business days. All appointments on and after August 21st will be cancelled. We will contact you to reschedule your appointment under the new system.

x

HIV Studies

Whitman-Walker Health is on the cutting edge of HIV research.  We conduct clinical trials to test new medications, study the long-term effects of HIV through observational cohorts, and help translate scientific findings into community practice.  We strive to establish the value and advantages of integrating sound research in community settings.  We invite you to read more about the various HIV studies at Whitman-Walker and to visit the FAQ page  to learn more about becoming a research patient for the first time or joining a study.  You can also visit the Currently Enrolling page to learn about open HIV studies.

Clinical Trials

Testing new HIV treatments gives our patients access to the latest medications and easiest to take regimens in development.  Whitman-Walker has a long history of studying HIV treatment. Starting in 1987, Whitman-Walker participated in trials on AZT, the first antiretroviral therapy for HIV. Subsequently, the health center was closely involved with trials on the first protease inhibitors which revolutionized HIV care in 1996. Since then, science has made impressive advancements in both the efficacy and tolerability of HIV treatments. Today we are studying multiple regimens that can be taken as “one pill, once a day” and are associated with very few side effects or subclinical conditions. You and your doctor should talk about your health and medications if you are thinking about joining a study.  If you have questions about HIV clinical trials at our site, you can call 202-745-6172 to speak to a study coordinator.

Observational Cohort Studies

Since HIV is a chronic condition, studying its long-term effects on the human body is critical. In order to do this, Whitman-Walker is part of two important cohort studies which track both the physical health and quality of life of people with HIV. Participating in these studies can be a lifetime commitment, so the health center is very appreciative of all those who have been so generous with their time.

SHARE (Study to Help the AIDS Research Effort)  is the Washington, DC/Baltimore site of the Multicenter AIDS Cohort Study. The study began in 1984 and continues to make significant contributions to scientists’ understanding of HIV. You can search scientific reports from SHARE here.

DC Cohort  began in 2011 as a way to study the health care of people with HIV in the District of Columbia. The DC Cohort is the only city-wide cohort study on HIV in the world.